These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5339569)

  • 1. Preparation and antibacterial activity of some spiramycin derivatives.
    Adamski RJ; Heymann H; Geftic SG; Barkulis SS
    J Med Chem; 1966 Nov; 9(6):932-4. PubMed ID: 5339569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Syntheses of trimethyl pyrazine derivatives and their antibacterial properties].
    Yamanishi Y; Kawasaki N
    Yakugaku Zasshi; 1967 Jan; 87(1):105-7. PubMed ID: 5342543
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application of acetyl spiramycin to urinary tract infections].
    Shigematsu S; Okochi T; Noda S
    J Antibiot B; 1966 Aug; 19(4):297-304. PubMed ID: 4961327
    [No Abstract]   [Full Text] [Related]  

  • 4. Fusidic acid derivatives. I. Relationship between structure and antibacterial activity.
    Godtfredsen WO; Von Daehne W; Tybring L; Vangedal S
    J Med Chem; 1966 Jan; 9(1):15-22. PubMed ID: 4959882
    [No Abstract]   [Full Text] [Related]  

  • 5. [Control of antibacterial activity of saliva, after administration of spiramycin, on some bacterial strains found in periodontal disease patients].
    Marin F; Travaglini AP
    Friuli Med; 1964; 19(6):1111-9. PubMed ID: 5827871
    [No Abstract]   [Full Text] [Related]  

  • 6. Spiramycin resistance in Staphylococcus aureus. Decrease in spiramycin-accumulation and the ribosomal affinity of spiramycin in resistant staphylococci.
    Shimizu M; Saito T; Hashimoto H; Mitsuhashi S
    J Antibiot (Tokyo); 1970 Feb; 23(2):63-7. PubMed ID: 5416652
    [No Abstract]   [Full Text] [Related]  

  • 7. The bacteriostatic effectiveness of 1-alkyl-3-(3,4-dichlorophenyl)ureas.
    Schenach TA; Brown J; Wysocki AJ; Yackovich F
    J Med Chem; 1966 May; 9(3):426-8. PubMed ID: 5335678
    [No Abstract]   [Full Text] [Related]  

  • 8. Spiramycin resistance in Staphylococcus aureus. The stoichiometry of spiramycin-binding to ribosomes from spiramycin-sensitive, intermediate- and high-resistant strains.
    Shimizu M; Saito T; Mitsuhashi S
    Jpn J Microbiol; 1970 Mar; 14(2):177-8. PubMed ID: 5309854
    [No Abstract]   [Full Text] [Related]  

  • 9. Ribosomes from spiramycin resistant mutants of Escherichia coli Q13.
    Tanaka K; Tamaki M; Itoh T; Otaka E; Osawa S
    Mol Gen Genet; 1972; 114(1):23-30. PubMed ID: 4552496
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel dimeric derivatives of leucomycins and tylosin, sixteen-membered macrolides.
    Omura S; Miyano K; Matsubara H; Nakagawa A
    J Med Chem; 1982 Mar; 25(3):271-5. PubMed ID: 7040661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study on the antistaphylococcal activity of acetyl-spiramycin].
    Kawamori Y; Tanaka S; Tomimatsu S
    J Antibiot B; 1967 Feb; 20(1):10-1. PubMed ID: 5299296
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity to spiramycin of thromycin-resistant strains of Staphylococcus aureus isolated from clinical sources.
    Whelan JP; Pugh IM
    Med J Aust; 1969 May; 1(22):1132-3. PubMed ID: 4893256
    [No Abstract]   [Full Text] [Related]  

  • 13. The production of resistance to spiramycin in a population of Staphylococcus aureus.
    Frost AJ
    Aust J Exp Biol Med Sci; 1967 Jun; 45(3):283-7. PubMed ID: 6048744
    [No Abstract]   [Full Text] [Related]  

  • 14. Cross resistance of Escherichia coli B. ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Rychlík I; Cerná J
    Hoppe Seylers Z Physiol Chem; 1968 Aug; 349(8):958-9. PubMed ID: 4878426
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosemigramicidin S.
    Waki M; Izumiya N
    J Am Chem Soc; 1967 Mar; 89(5):1278-9. PubMed ID: 5342652
    [No Abstract]   [Full Text] [Related]  

  • 16. The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.
    Dibb WL; Ragnhildstveit E
    NIPH Ann; 1986 Dec; 9(2):61-3. PubMed ID: 3101004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetyl spiramycin].
    Nakamura T; Matsumoto K; Saito J
    J Antibiot B; 1966 Dec; 19(6):428-31. PubMed ID: 5298388
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of pH on spiramycin and on gram negative bacilli].
    Lorian V
    Presse Med (1893); 1969 May; 77(27):974. PubMed ID: 4893914
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic study on the combined use of spirazmycin and chloramphenicol].
    Nakazawa S; Inoue T; Irie R; Owada M; Okajima H
    Jpn J Antibiot; 1968 Aug; 21(4):183-7. PubMed ID: 4884745
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basic and clinical study of acetyl-spiramycin].
    Shimizu K; Jindate T; Shimada K; Okumura A
    J Antibiot B; 1966 Dec; 19(6):423-7. PubMed ID: 5298387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.